SoftBank is reportedly preparing to take its next big bet public in the United States, with plans to list a newly formed AI and robotics business called “Roze” as soon as this year. The idea, according to the reporting, is straightforward: Masayoshi Son wants to move quickly, and he wants Roze to be positioned where the capital markets are most eager to price the future—especially the future that sits at the intersection of artificial intelligence, automation, and physical-world robotics.
For investors and industry watchers, the significance isn’t only that SoftBank is pursuing another IPO. It’s that the company appears to be trying to translate a long-running strategy—backing ambitious technology themes—into a more direct, public-market narrative. In other words, Roze would not just be another private venture under the SoftBank umbrella. It would be a standalone story designed for scrutiny, valuation, and momentum in a market that has repeatedly rewarded companies that can credibly connect AI capabilities to real-world deployment.
What makes this moment feel different is the timing. AI has moved from “promising” to “everywhere,” but robotics remains the harder part of the equation. Software can scale quickly; robots must operate reliably in messy environments, integrate with existing workflows, and prove they can deliver measurable outcomes. That gap—between impressive demos and dependable industrial or consumer performance—is where many AI-and-robotics efforts struggle. If SoftBank is serious about an IPO timeline “as soon as this year,” it suggests Roze is already far enough along to present a coherent plan for productization, partnerships, and revenue pathways, even if details remain limited.
Roze, as described in the reporting, is focused on AI and robotics. That pairing matters because it signals a shift away from treating robotics as a purely mechanical domain. Modern robotics increasingly depends on AI for perception, planning, and decision-making—capabilities that can improve over time as models get better and data pipelines mature. But the reverse is also true: robotics can generate unique data that improves AI systems in ways that purely digital environments cannot. A company that can close that loop—deploy robots, collect operational data, refine models, and then redeploy—can build a compounding advantage. The market will likely want to know whether Roze has a strategy for that loop, not just a vision.
SoftBank’s history adds another layer to how this should be interpreted. Masayoshi Son has long been associated with bold, sometimes contrarian bets, and SoftBank has repeatedly tried to turn emerging technologies into scalable platforms. Yet the company’s most famous successes have often come from identifying the right theme early and then backing it with capital and ecosystem-building. The IPO of Roze would represent a different kind of maturity: moving from “we believe” to “we can execute and report.” Public markets demand clarity—what the product is, who buys it, what the margins look like, and how the company defends itself against competitors.
That pressure can be uncomfortable for companies still in the middle of building. But it can also force discipline. If Roze is truly aiming for a listing this year, it implies that SoftBank believes the company can withstand that scrutiny. It also implies that SoftBank sees a window of opportunity in US markets—an environment where investors continue to seek exposure to AI infrastructure, AI applications, and automation narratives, even as they have become more selective about which stories deserve premium valuations.
There is also a strategic reason to list in the United States rather than elsewhere. The US capital markets are not just deeper; they are also more tightly connected to the AI and robotics ecosystem—cloud providers, semiconductor supply chains, enterprise buyers, and research networks. A US listing can make it easier to attract institutional investors who specialize in technology and to build credibility with partners who prefer dealing with companies that are already subject to public-company governance standards. For Roze, that could translate into faster partnership formation, more visibility for talent recruitment, and potentially better access to follow-on funding if needed.
Still, the most important question is what Roze will actually do once it becomes a public company. AI and robotics can mean many things: humanoid robots, warehouse automation, autonomous mobile robots, robotic arms for manufacturing, service robots for hospitality or healthcare, or even robotics-as-a-platform where the company sells software and orchestration rather than hardware alone. Each path has different economics, different regulatory hurdles, and different timelines to scale.
The reporting indicates the focus is on AI and robotics, but it doesn’t spell out the exact product line in the information provided here. That means the market will likely watch for additional disclosures—whether through filings, investor communications, or credible third-party reporting—to understand Roze’s specific approach. Investors will want to know whether Roze is building robots that are primarily hardware-first, software-first, or a hybrid. They will also want to know whether Roze’s AI is trained on proprietary data, whether it relies on third-party model providers, and how it handles the operational realities that break many robotics deployments: edge cases, sensor noise, changing lighting conditions, mechanical wear, and the need for safe behavior around humans.
A unique angle on this story is how SoftBank may be trying to reframe the robotics narrative for public investors. Historically, robotics has been treated as cyclical and capital-intensive. Hardware businesses can be expensive to scale, and unit economics can be difficult to forecast. But AI can change the framing by making robotics more adaptable and by enabling software-like improvements over time. If Roze can demonstrate that its systems become more capable with each deployment—through learning, updates, and continuous optimization—it could help investors view robotics less as a one-time hardware sale and more as an evolving platform.
That platform framing is crucial because it affects valuation. Public markets tend to reward recurring revenue, predictable adoption curves, and clear pathways to margin expansion. If Roze can sell not only robots but also ongoing AI services—maintenance, upgrades, analytics, workflow integration, or usage-based pricing—then the company’s financial story becomes more resilient. Even if hardware remains a component, the recurring layer can stabilize growth expectations.
Another factor that will shape Roze’s prospects is competition. The AI-and-robotics space is crowded, with major technology firms, robotics specialists, and startups all vying for dominance. Some competitors have deep resources and established distribution channels. Others have strong technical teams but struggle with commercialization. SoftBank’s advantage, if any, would likely come from its ability to mobilize capital, attract partners, and accelerate go-to-market execution. But in a public-market context, those advantages must show up in measurable milestones: customer contracts, pilot programs converting to production, and evidence that Roze’s technology performs better or costs less than alternatives.
The “as soon as this year” timeline also raises questions about readiness. IPOs are not just about ambition; they require legal preparation, financial auditing, corporate structuring, and a level of operational maturity that can survive investor due diligence. That doesn’t necessarily mean Roze is already generating large revenues. It could mean SoftBank believes the company can present a credible forward plan and that the market will accept early-stage metrics if the narrative is compelling and the leadership team is strong. Still, the closer the timeline gets, the more likely it becomes that Roze will need to provide clearer signals about traction.
In that sense, the IPO rumor can be read as a form of market signaling. SoftBank may be testing investor appetite for a new AI-and-robotics vehicle, gauging whether the public markets will reward the theme with sufficient valuation to justify the listing. If investor sentiment is strong, the company can proceed with confidence. If sentiment is weaker, SoftBank might adjust the timing or structure. Either way, the process itself becomes a barometer for how the market is thinking about robotics now—whether it sees robotics as a near-term commercial opportunity or a longer-horizon bet.
There is also a broader implication for the industry: if SoftBank successfully brings Roze to the US market quickly, it could encourage other private AI-and-robotics companies to consider similar paths. Public listings can validate categories and attract more capital, which then accelerates competition and innovation. But it can also raise the bar for transparency and performance. Companies that can’t articulate a clear commercialization strategy may find it harder to raise funds later. In that way, Roze’s IPO could become a forcing function for the sector.
For readers trying to understand what to watch next, the most actionable items are the ones that would clarify Roze’s credibility and execution. First, any official filing details and the timing of the listing will matter—not just the date, but the structure. Will Roze be a full spin-out with its own management and financial reporting? Will SoftBank retain significant control? How much of the company’s value is tied to tangible assets versus intellectual property and future growth expectations? These details influence how investors interpret risk.
Second, the description of Roze’s platform and partnerships will likely determine whether the story is seen as visionary or merely speculative. Partnerships can be a shortcut to commercialization: manufacturing partners, logistics providers, enterprise customers, or technology suppliers. If Roze can name credible collaborators and show how those relationships translate into deployments, it strengthens the case that the company is building something that can survive contact with real operations.
Third, the IPO structure itself—how shares are offered, what valuation range is implied, and how the company positions its growth narrative—will reveal how much investor demand exists for AI-and-robotics exposure. In recent years, markets have shown that they can be enthusiastic about AI, but they can also punish companies that fail to show a path to revenue. Roze’s offering will likely reflect that balance: enough optimism to attract capital, enough specificity to satisfy due diligence.
Finally, there is the human element that often gets overlooked in IPO stories: leadership and talent. Robotics is not only a technology challenge; it’s an engineering and operations challenge. It requires expertise across computer vision, machine learning, control systems, hardware design, safety engineering, and deployment logistics. If Roze is moving toward a public